Literature DB >> 29371392

How does inflammation contribute to pulmonary hypertension?

Rahul Kumar1, Brian Graham2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29371392      PMCID： PMC5973838          DOI： 10.1183/13993003.02403-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  30 in total

1.  Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.

Authors:  Eleni Vergadi; Mun Seog Chang; Changjin Lee; Olin D Liang; Xianlan Liu; Angeles Fernandez-Gonzalez; S Alex Mitsialis; Stella Kourembanas
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

2.  Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma.

Authors:  Hanadi Dib; Mathieu C Tamby; Guillaume Bussone; Alexis Regent; Alice Berezné; Claudine Lafine; Cédric Broussard; Gérald Simonneau; Loïc Guillevin; Véronique Witko-Sarsat; Marc Humbert; Luc Mouthon
Journal:  Eur Respir J       Date:  2011-10-17       Impact factor: 16.671

Review 3.  The Importance of Dendritic Cells in Maintaining Immune Tolerance.

Authors:  Cindy Audiger; M Jubayer Rahman; Tae Jin Yun; Kristin V Tarbell; Sylvie Lesage
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

4.  Three Unique Interstitial Macrophages in the Murine Lung at Steady State.

Authors:  Sophie L Gibbings; Stacey M Thomas; Shaikh M Atif; Alexandra L McCubbrey; A Nicole Desch; Thomas Danhorn; Sonia M Leach; Donna L Bratton; Peter M Henson; William J Janssen; Claudia V Jakubzick
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

Review 5.  Systemic sclerosis--challenges for clinical practice.

Authors:  Zsuzsanna H McMahan; Laura K Hummers
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

6.  Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.

Authors:  Robert J Aiello; Patricia-Ann Bourassa; Qing Zhang; Jeffrey Dubins; Daniel R Goldberg; Stéphane De Lombaert; Marc Humbert; Christophe Guignabert; Maria A Cavasin; Timothy A McKinsey; Vishwas Paralkar
Journal:  J Pharmacol Exp Ther       Date:  2016-12-07       Impact factor: 4.030

Review 7.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch; Christophe Guignabert; Marc Humbert; Mark R Nicolls
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

8.  Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension.

Authors:  Rasa Tamosiuniene; Wen Tian; Gundeep Dhillon; Lijuan Wang; Yon K Sung; Lajos Gera; Andrew J Patterson; Rani Agrawal; Marlene Rabinovitch; Kelly Ambler; Carlin S Long; Norbert F Voelkel; Mark R Nicolls
Journal:  Circ Res       Date:  2011-08-25       Impact factor: 17.367

9.  Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study.

Authors:  Sirisha Kommireddy; Srinivas Bhyravavajhala; Kishorebabu Kurimeti; Srinivasa Chennareddy; Suresh Kanchinadham; Irlapati Rajendra Vara Prasad; Liza Rajasekhar
Journal:  Rheumatology (Oxford)       Date:  2015-04-29       Impact factor: 7.580

10.  Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension.

Authors:  Takahiro Hashimoto-Kataoka; Naoki Hosen; Takashi Sonobe; Yoh Arita; Taku Yasui; Takeshi Masaki; Masato Minami; Tadakatsu Inagaki; Shigeru Miyagawa; Yoshiki Sawa; Masaaki Murakami; Atsushi Kumanogoh; Keiko Yamauchi-Takihara; Meinoshin Okumura; Tadamitsu Kishimoto; Issei Komuro; Mikiyasu Shirai; Yasushi Sakata; Yoshikazu Nakaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205
View more
  10 in total

1.  Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.

Authors:  Sean Agbor-Enoh; Michael A Solomon; Samuel B Brusca; Jason M Elinoff; Yvette Zou; Moon Kyoo Jang; Hyesik Kong; Cumhur Y Demirkale; Junfeng Sun; Fayaz Seifuddin; Mehdi Pirooznia; Hannah A Valantine; Carl Tanba; Abhishek Chaturvedi; Grace M Graninger; Bonnie Harper; Li-Yuan Chen; Justine Cole; Manreet Kanwar; Raymond L Benza; Ioana R Preston
Journal:  Circulation       Date:  2022-08-25       Impact factor: 39.918

2.  Extracellular matrix degradation pathways and fatty acid metabolism regulate distinct pulmonary vascular cell types in pulmonary arterial hypertension.

Authors:  Sharon Mumby; F Perros; C Hui; B L Xu; W Xu; V Elyasigomari; A Hautefort; G Manaud; M Humbert; K F Chung; S J Wort; I M Adcock
Journal:  Pulm Circ       Date:  2021-03-02       Impact factor: 3.017

Review 3.  Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension.

Authors:  Thenappan Thenappan; Stephen Y Chan; E Kenneth Weir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-24       Impact factor: 4.733

4.  Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex.

Authors:  Marina Zemskova; Nolan McClain; Maki Niihori; Mathews V Varghese; Joel James; Ruslan Rafikov; Olga Rafikova
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

5.  3-Bromopyruvate alleviates the development of monocrotaline-induced rat pulmonary arterial hypertension by decreasing aerobic glycolysis, inducing apoptosis, and suppressing inflammation.

Authors:  Jie Liu; Wang Wang; Lei Wang; Xian-Mei Qi; Yu-Hui Sha; Ting Yang
Journal:  Chin Med J (Engl)       Date:  2020-01-05       Impact factor: 2.628

Review 6.  Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?

Authors:  Kondababu Kurakula; Valérie F E D Smolders; Olga Tura-Ceide; J Wouter Jukema; Paul H A Quax; Marie-José Goumans
Journal:  Biomedicines       Date:  2021-01-09

Review 7.  Treating Inflammation Associated with Pulmonary Hypertension: An Overview of the Literature.

Authors:  Hugo Hyung Bok Yoo; Flávia Luiza Marin
Journal:  Int J Gen Med       Date:  2022-02-03

8.  Expression Quantitative Trait Locus Mapping in Pulmonary Arterial Hypertension.

Authors:  Anna Ulrich; Pablo Otero-Núñez; John Wharton; Emilia M Swietlik; Stefan Gräf; Nicholas W Morrell; Dennis Wang; Allan Lawrie; Martin R Wilkins; Inga Prokopenko; Christopher J Rhodes; On Behalf Of The Nihr BioResource-Rare Diseases Consortium; Uk Pah Cohort Study Consortium
Journal:  Genes (Basel)       Date:  2020-10-22       Impact factor: 4.096

9.  Intestinal Dysbiosis and the Developing Lung: The Role of Toll-Like Receptor 4 in the Gut-Lung Axis.

Authors:  Stephen Wedgwood; Kimberly Gerard; Katrina Halloran; Ashley Hanhauser; Sveva Monacelli; Cris Warford; Phung N Thai; Nipavan Chiamvimonvat; Satyan Lakshminrusimha; Robin H Steinhorn; Mark A Underwood
Journal:  Front Immunol       Date:  2020-03-05       Impact factor: 7.561

10.  Ethyl Pyruvate Alleviates Pulmonary Hypertension through the Suppression of Pulmonary Artery Smooth Muscle Cell Proliferation via the High Mobility Group Protein B1/Receptor for Advanced Glycation End-Products Axis.

Authors:  Chuanzhen Liu; Hourong Sun; Mengmeng Tang; Jianhua Li; Xiquan Zhang; Guangqing Cao
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-05-19       Impact factor: 1.520
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.